News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Ruben Mesa: Pelabresib plus Ruxolitinib for JAKi naive Myelofibrosis
Ruben Mesa/vjhemonc.com
Mar 12, 2025, 10:16

Ruben Mesa: Pelabresib plus Ruxolitinib for JAKi naive Myelofibrosis

Ruben Mesa, President and Executive Director of Atrium Health Levine Cancer Institute and Atrium Health Wake Forest Baptist Comprehensive Cancer Center, shared an article by Raajit K. Rampal, et al. on LinkedIn:

“Honored to have joined many wonderful colleagues in these important PhaseIII trial data for combination Pelabresib plus Ruxolitinib for JAKi naive myelofibrosis.”

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial.

Authors: Raajit K. Rampal, et al.

Ruben Mesa: Pelabresib plus Ruxolitinib for JAKi naive Myelofibrosis

Atrium Health Levine Cancer Institute Atrium Health Wake Forest Baptist Comprehensive Cancer Center cancer fight against cancer Global fight against cancer myelofibrosis OncoDaily Oncology Pelabresib Raajit K. Rampal Ruben Mesa ruxolitinib
Special Coverage
Science
Mar 12, 2025, 10:16
Ruben Mesa: Pelabresib plus Ruxolitinib for JAKi naive Myelofibrosis
Blog
Mar 12, 2025, 10:14
Ramy Sedhom: Very inspired after reviewing Symptom Science and Supportive Care abstracts for ASCO25
Blog
Mar 12, 2025, 10:09
Discussing prognosis with patients living with advanced cancers - Common Sense Oncology
Science
Mar 12, 2025, 10:06
Michelle Leung: Experimental models and high-throughput sequencing in metastasis research
Blog
Mar 12, 2025, 09:59
AACR Cancer and Biomedical Research Career Fair
Science
Mar 12, 2025, 09:58
Myeloma Paper of the Day, March 12th, suggested by Robert Orlowski
Science
Mar 12, 2025, 09:53
Teresa Amaral: Adjuvant Treatment for Stage III BRAF V600-Mutated Melanoma
Insight
Mar 12, 2025, 09:45
Chris Boshoff: Phase 3 results for PROTAC ER degrader in advanced or metastatic breast cancer
Blog
Mar 12, 2025, 09:42
Europe is a heatmap of inequalities in cancer care said Professor Csaba Dégi - European Cancer Organisation
Blog
Mar 12, 2025, 09:34
Carmen Monge-Montero: Katell Maguet is raising funds for colorectal cancer research
Science
Mar 12, 2025, 09:19
Brigitte Maes: The power of collaboration among key stakeholders working toward a common goal
Blog
Mar 12, 2025, 09:17
5 new factsheets packed with essential cancer prevention tips by the Association of European Cancer Leagues